In simulated comparisons, the novel oral anticoagulants ranked better than VKA or antiplatelet therapies for prevention of stroke, ischaemic stroke or systemic embolism and mortality. Conclusions In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback